2024³â ´ëÇÑ°ñ¹ÝÅëÇÐȸ Á¦12Â÷ ½ÉÆ÷Áö¾ö : 2024-04-07
±³À°ÀÏÀÚ : 2024-04-07
±³À°Àå¼Ò : Á߾Ӵ뺴¿ø(Èæ¼®µ¿) Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ
±³À°ÁÖÁ¦ : 2024³â ´ëÇÑ°ñ¹ÝÅëÇÐȸ Á¦12Â÷ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑÆó°æÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ°ñ¹ÝÅëÇÐȸ
´ã´çÀÚ : ±è¼öÇü
¿¬¶ôó : 02-6958-5864
À̸ÞÀÏ : kpps.info@gmail.com
±³À°Á¾·ù : ³»°ú, »êºÎÀΰú, ºñ´¢ÀÇÇаú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í "- Àü¹®ÀÇ: 5¸¸¿ø, Àü°øÀÇ: 3¸¸¿ø
- 65¼¼ ÀÌ»ó : ¹«·á"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 09:00~09:15 2023 Guideline: ¿ªÇÐ, ¿øÀÎ, º´Å»ý¸® ±èÅÂÇö(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 09:15~09:30 2023 Guideline: Áø´Ü ³²±ÃÁ¤(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 09:30~09:45 2023 Guideline: Ä¡·á ÇÑÁö¿¬(¼¿ïÀÇ´ë)
Åä·Ð 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 09:45~10:00 Q&A ( )
ÈÞ½Ä 04¿ù 07ÀÏ 10:00~10:20 Coffee break ( )
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 10:20~10:35 Pathophysiology of chronic pelvic pain - central and peripheral sensitization À̵¿À±(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 10:35~10:50 Pharmacological management ¼Û¼ö¿¬(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 10:50~11:05 Surgical management È«Á¤¾Æ(¼øõÇâÀÇ´ë)
Åä·Ð 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 11:05~11:20 Q&A ( )
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 11:20~11:35 Korean STI Guidelines, 2023 ±¸À¯Áø(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 11:35~11:50 Cause and Treatment of Adolescent CPP À±º¸Çö(¿¬¼¼ÀÇ´ë)
Åä·Ð 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 11:50~12:05 Q&A ( )
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 12:05~12:20 Present and future of Chronic pelvic pain ÇãÁÖ¿±(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 12:20~12:35 Guadix: anti-adhesion barrier À¯Á¤¹Î(´ë±¸°¡Å縯ÀÇ´ë)
½Ä»ç 04¿ù 07ÀÏ 12:35~13:50 Lunch ( )
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 13:50~14:05 Bladder pain syndrome, Irritable bowel syndrome ¹Ú¼Ò¿¬(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 14:05~14:20 Connective tissue diseases and CPP ½ÉÀ¯Áø(Áß¾ÓÀÇ´ë)
Åä·Ð 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 14:20~14:35 Q&A ( )
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 14:35~14:50 Chronic pelvic pain after radiotherapy and chemotherapy in gynecologic cancers ¾î°æÁø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 14:50~15:05 Opioid dose titration for cancer pain °æ¹Î¼±(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 15:05~15:20 Intervention for intractable cancer pain ¹ÚÇö(Â÷ÀÇ°úÇдë)
Åä·Ð 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 15:20~15:35 Q&A ( )
ÈÞ½Ä 04¿ù 07ÀÏ 15:35~15:55 Coffee break ( )
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 15:55~16:10 Laparoscopic neurolysis for neuropathic pain ±èµµ±Õ(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 16:10~16:25 Pain arising from pelvic mesh implants ÀÌ»ç¶ó(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 16:25~16:40 Minimal invasive surgery for endometriosis associated pain ÁÖÁ¾±æ(ºÎ»êÀÇ´ë)
Åä·Ð 04¿ù 07ÀÏ Á߾Ӵ뺴¿ø(Èæ¼®µ¿)Áß¾Ó°ü 4Ãþ ¼ÛºÀȦ 16:40~16:55 Q&A ( )